Log in
Register|
Norah ★ Tunisia, 2018-04-02 14:29 (3004 d 17:09 ago) Posting: # 18630 Views: 4,424 |
|
|
Hello I need your advice please regarding this : if ever a drug combination (like candesartan hydrochlorothiazide) has demonstrated its BE with the princeps, is it mandatory to perform study for candasertan alone (same pharmaceutical company, same dosage) Thanks ! |
|
Beholder ★ Russia, 2018-04-09 11:04 (2997 d 20:35 ago) @ Norah Posting: # 18655 Views: 3,186 |
|
|
Hi, Norah! ❝ (same pharmaceutical company, same dosage) What about excipients? The same quality and quantity? — Best regards Beholder |
|
Norah ★ Tunisia, 2018-04-10 17:26 (2996 d 14:12 ago) @ Beholder Posting: # 18661 Views: 3,152 |
|
|
Hello Beholder Yes all is the same |
|
balakotu ★ India, 2018-04-13 08:40 (2993 d 22:58 ago) (edited on 2018-04-13 10:22) @ Norah Posting: # 18675 Views: 3,095 |
|
|
Hello Norah, As per USFDA, it is mandatory to perform separate studies for separate products. FDA will not accept plain candesartan ANDA without BE studies. Moreover, candesartan a BCS class II product and waiver approach (based on combination product BE study) is not possible to get the waiver for plain Candesartan. Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe] |
Ing. Helmut Schütz